VWA
VKTX icon

Visionary Wealth Advisors’s Viking Therapeutics VKTX Stock Holding History

Visionary Wealth Advisors’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$747K Sell
19,154
-3,625
-16% -$117K 0.03% 361
2026
Q1 		$741K Buy
22,779
+2,153
+10% +$69.2K 0.03% 330
2025
Q4 		$726K Sell
20,626
-1,024
-5% -$36.3K 0.03% 317
2025
Q3 		$569K Buy
21,650
+13,553
+167% +$404K 0.03% 363
2025
Q2 		$215K Sell
8,097
-5,077
-39% -$134K 0.01% 539
2025
Q1 		$318K Buy
+13,174
New +$416K 0.02% 427
2024
Q4 		– Sell
-3,639
Closed -$230K – 563
2024
Q3 		$230K Buy
+3,639
New +$213K 0.01% 490

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Visionary Wealth Advisors's VKTX Position: Q2 2026 in Review

Visionary Wealth Advisors reduced its Viking Therapeutics (VKTX) stake by 16% in Q2 2026, selling an estimated $117K and leaving 19,154 shares worth $747K. The position accounts for 0.03% of the portfolio, ranked #361.

Visionary Wealth Advisors first reported a position in VKTX in Q3 2024 and has held it in 7 quarters since. 434 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Visionary Wealth Advisors held 19,154 shares of Viking Therapeutics worth $747K as of Q2 2026.
  • Visionary Wealth Advisors sold 3,625 Viking Therapeutics shares in Q2 2026, an estimated $117K.
  • Viking Therapeutics made up 0.03% of Visionary Wealth Advisors's portfolio in Q2 2026, its #361 holding.
  • Visionary Wealth Advisors first reported a position in Viking Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 434 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Visionary Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.